Old Web
English
Sign In
Acemap
>
authorDetail
>
F. Sinicrope
F. Sinicrope
Medicine
Pancreatic cancer
Cancer research
Apoptosis
Sulindac sulfide
3
Papers
5
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized phase II study of the efficacy and safety of gemcitabine plus TH-302 versus gemcitabine alone in previously untreated patients with advanced pancreatic cancer.
2011
Journal of Clinical Oncology
Mitesh J. Borad
Darren Sigal
Hope E. Uronis
Joe Stephenson
Nathan Bahary
Mark U. Rarick
L. C. DeMarco
T. J. Finnegan
E. G. Chiorean
David P. Ryan
Allen Lee Cohn
Brian Ulrich
V. C. Harish
E. N. Anderes
Wen Wee Ma
P. P. Yu
F. Sinicrope
Clarence Eng
U. K. Sunkara
Shantan G. Reddy
Show All
Source
Cite
Save
Citations (5)
Small molecule Bcl-2 inhibitor enhances apoptosis induction by gemcitabine or sulindac sulfide in BxPC-3 pancreatic cancer cells
2004
Journal of Clinical Oncology
E. N. Freeburg
F. Sinicrope
Show All
Source
Cite
Save
Citations (0)
Bcl-2 overexpression attenuates apoptosis induction by sulindac sulfide in SW480 human colon cancer cells
2004
Journal of Clinical Oncology
R. Penington
F. Sinicrope
Show All
Source
Cite
Save
Citations (0)
1